Victory for drugmakers GSK and Boehringer in $640 million Zantac cancer lawsuit 24.05.2024 12:15 Fortune.com GSK said the outcome is “consistent with the scientific consensus that there is no consistent or reliable evidence” of increased cancer risks from Zantac. Read More